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Abstract: BACKGROUND: Actinic cheilitis, a common disease caused by chronic solar exposure and tobacco use, is considered
a premalignant lesion with potential to develop into squamous cell carcinoma. Some of the available treatments are invasive,
have unaesthetic results and require multiple sessions. 
OBJECTIVE: To assess the efficacy of a therapy and its cosmetic results. 
METHODS: In this uncontrolled clinical trial a single photodynamic therapy (PDT) session using 16% methyl-aminolevulinate
was performed on actinic cheilitis of the lower lip. A standardized questionnaire was applied in order to assess the clinical
improvement from the patients' point of view and the satisfaction with the treatment. Anatomopathological evaluation was
performed before the treatment and two months afterwards. 
RESULTS: The sample was composed of 19 patients (10 males and 9 females), phototypes I to III, with average age of 62 years.
Main adverse effects were: sudden pain, scabs, herpes flare-up, and edema. The average score of pain during the procedure
was 5,8+2,9. At the final assessment the patients reported improvement of 80% and satisfaction of 85% (p<0.01).
Anatomopathological analysis showed a significant decrease of dysplasia (p=0.03) in spite of its presence in 84% of cases.
There was no significant correlation between the level of dysplasia with either the subjective impression of clinical improve-
ment (p=0.82) or with the patients’ final satisfaction (p=0.96). 
CONCLUSION: PDT is effective in the treatment of actinic cheilitis, but it is associated with a significant level of pain. Due to the
persistence of dysplasia, more research needs to be done in order to define the ideal number of sessions for the effective
treatment of these lesions.
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INTRODUCTION
Actinic cheilitis is a common condition, mostly
located on the lower lip, resulting from chronic solar
exposure. It is also associated with smoking.1 As with
other actinic skin keratoses, it is considered a pre-
malignant lesion which could develop into squamous
cell carcinoma (SCC).2 Markopoulos, Albanidou-
Farmaki and Kayavis reported a development into
SCC of 16.9% of 65 cases of actinic cheilitis.1 It is
known that the risk of metastasis from SCC in the lip
is 4 times higher that from cutaneous SCC.1,3
Actinic cheilitis is characterized by erythema
and edema, progressing with atrophy, hyperkeratosis
and erosions or ulcerations. The main histological cri-
teria are atypia and the loss of polarity of the ker-
atinocytes of the lower portion of the epithelium,
associated with solar elastosis and inflammatory infil-
trate. The atypias can be classified as mild, moderate
or severe, according to the cellular alterations found.4
Histological subtypes of actinic cheilitis are also
described, taking into consideration findings like
hyperkeratosis, atrophy, acantholysis and lichenoid
pattern of the inflammatory infiltrate.  
There is some difficulty in using the usual ther-
apies for actinic keratoses in the lip, with lower cure
rates. The main treatments are the vermillionectomy,
CO2 or Erbium laser ablation and electro-dissection.
These treatments are invasive, require local or gener-
al anesthesia, and offer risk of unaesthetic scars as
well.5-7 Other therapeutic modalities used are topical
cryotherapy, retinoid, 5% fluorouracil (5-FU),
Imiquimod, diclofenac and chemical peels.8-11
Treatments with 5-FU or Imiquimod take a long time,
with important inflammatory reaction, and the collab-
oration of the patient is necessary.  High recurrence
rates of the lesions are observed with chemical peels.
Cryotherapy may result in blisters formation, impor-
tant pain and movement restriction in the treated
area.  Some studies, with a small number of patients,
demonstrated a good clinical and histopathological
response with the use of photodynamic therapy with
5-aminolevulinic acid and its methylate esther in the
treatment of actinic cheilitis.2,12-14
The topical photodynamic therapy (PDT) in the
treatment of non-melanoma skin cancer was
described in 1990 by Kennedy, Pottier and Pross.15
Nowadays it is widely used in the treatment of actinic
keratoses and superficial non-melanoma skin neo-
plasias.16 The high efficacy of PDT in the treatment of
actinic cheilitis was reported in various studies, with
cure rates between 70 and 90%, with good cosmetic
results and a high level of patient satisfaction.17,18 PDT,
performed with a combination of 5-aminolevulinic
acid (5-ALA) and blue light was approved by the FDA
for the treatment of actinic keratoses in 1999. This
therapeutic modality is based on the use of a tissue
photosensitizer, applied topically or systemically, and
subsequent irradiation with laser light or light bulb
(visible light between 400 and 700 nm), inducing cell
death by generating oxygen reactive species.19 In most
studies 5-ALA was used in cream or gel, in concentra-
tions from 3 to 20%. The addition of dimethyl sulfox-
ide increases the penetration of the 5-ALA. The methy-
late esther of 5-ALA, methyl aminolevulinate (MAL) or
methylaminomethylaminopentanoate (MAOP), was
subsequently developed for use in PDT. The MAL
shows a higher specificity for the neoplastic cells and
its use with red light was approved in 2003 for the
treatment of actinic keratoses in Germany.18,20
The objective of this study was to assess the effi-
cacy and applicability of PDT in the treatment of
actinic cheilitis, with clinical and anatomopathological
analyses, as well as analyses of the collateral effects
and clinical improvement assessed by the patient,
since less invasive approaches have been used more
often in the treatment of this disorder. 
MATERIAL AND METHODS 
This was an experimental, non controlled clini-
cal trial. Nineteen patients from spontaneous demand
of the general dermatology outpatients’ clinic seen
between April and June 2009 were selected based on a
clinical and anatomopathologic diagnosis of actinic
cheilitis. Patients with idiopathic immunosuppression
or immunosupression due to a specific disease or to
therapeutic reasons; porphyria; known allergy to MAL
or to a similar photosensitizing agent or excipient;
known hypersensitivity to nut products or to other
protein antigens; pregnancy; lactation; inadequate
contraception during treatment and for 1 month after-
wards in fertile age women; any condition which might
compromise the collaboration of the patient with the
study; regular UV treatment or treatment of the lower
lip with local therapy (including cryotherapy and
curettage) in the last 30 days or topical treatment
(including imiquimod, 5% fluorouracil and diclo-
fenac) in the last 3 months were excluded. All patients
signed the free and informed consent form and the
project was approved by the local Ethics Committee.
The size of the sample was defined based in
similar studies from indexed scientific literature.
12,13,14
Before the treatment the patients had a 3.0mm
punch biopsy a clinically most affected area of the
lower lip. Afterwards, a suture with 6.0 mononylon
suture was performed and the stitches were removed
in 7 days.
The patients were recruited and 16% methyl
aminolevulinate hydrochloride cream was applied
once to the lower lip and to a 5mm strip of adjacent
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skin, in a dark room. Crusts and scabs which might dis-
turb the treatment were carefully removed. A cotton
roll was used on the internal part of the lower lip for
better exposure of the area to be treated; the area was
covered with plastic film and subsequently a Black-out
tissue secured with micropore. Three hours after the
application the protection was removed. Then the
patients were exposed to a source of red light (LED)
with an emission peak of 630nm, 37 J/cm2 fluency,
71mw/cm2 potency (irradiancy) for a period of 8 min-
utes and 40 seconds, at a distance of 5 to 7 cm.
The patients were assessed immediately after
the procedure, after 7 days and after a period that var-
ied from 51 to 94 days (average of 62.5 days), when a
biopsy after the procedure was taken  (within the
same standards as the biopsy before the procedure).
The biopsy area chosen was based on the area with
the highest clinical severity. 
A standardized questionnaire applied to the
patients assessed the subjective impression of each of
them in terms of pain, improvement of the lesion, sat-
isfaction with the treatment and eventual complaints.
In order to evaluate the pain an analogical scale, vary-
ing from grade 0 (absence of pain) to grade 10 (most
severe pain) was used. The improvement of the lesion
was graded in percentages of 0% (absence of improve-
ment) to 100% (complete improvement of the lesion).
The level of satisfaction was also quantified in per-
centages of 0% (no satisfaction) to 100% (high satis-
faction with the treatment).
The pre and post treatment lip biopsies were
analyzed by an experienced dermatopathologist. The
anatomopathological criteria observed was the level
of epidermal dysplasia classified as discrete, moderate
and severe.  
Categorical variables were represented by per-
centages and analyzed by the chi-square or the
Fisher´s exact tests. The continuous variables had the
normality of their distributions verified by the
Shapiro-Wilk test and compared by the Student T and
Wilcoxon tests. They were represented by averages
and standard deviations or medians and interquartile
deviations, according to the distribution. The correla-
tions were analyzed by the non-parametric Spearman
test. The multivariate analysis of the characteristics
related to the patient final satisfaction (dependable
variable) was performed by the co-variance analysis
(ANCOVA) with the following independent variables:
age, score of immediate pain and impression of clini-
cal improvement after 60 days. P-values lower than
0,05 were considered significant.
RESULTS
Nineteen patients were included, 53% (10/19)
men and 47% (9/19) women. The age varied from 35
to 78 years, with an average of 62±11 years. The
patient's phototypes varied from I to III on the
Fitzpatrick classification. The complications observed
after the procedure were, in decreasing order of fre-
quency, immediate pain, crusts, herpes labialis,
edema, scaling, erythema, itch and paresthesia. 
The average score of pain referred during the
procedure was 5,8±2,9 (median=5), while between
the 1st and 7th day it was practically absent, with a
median of 0 (p<0,01 - Wilcoxon). The median of the
subjective impression of clinical improvement of the
lesions by the patients, on the 7th day was de 50±70,
increasing significantly to 80±40 2 months after the
application (p<0,01 - Wilcoxon). The patients´ final
satisfaction after 60 days had a median of 80±40.
According to the multivariate analysis by ANCOVA this
satisfaction correlated directly with the level of clinical
improvement of the lesion and inversely with the age
of the patient, and it was not significantly influenced
by the pain score attributed to the procedure (Table 1).
Actinic cheilitis lesions before and at 2 months after
treatment with photodynamic therapy are illustrated
in the figures 1 and 2.
As for the anatomopathological analysis, from
the 19 initial biopsies 18 had the common variant of
actinic cheilitis and 1 the lichenoid variant. The level
of pre-treatment dysplasia was discrete in 17 lesions
and moderate in 2, and there was a significant
decrease on the level of dysplasia after treatment
(p=0,03 – Chi-square tendency), however 84% of the
cases still had some level of dysplasia (Figure 3)
There was no significant correlation between
the level of dysplasia and the subjective impression of
clinical improvement (p=0,82 - Spearman) or with
the final patients´ satisfaction (p=0,96 - Spearman).
TABLE 1: Multivariate analysis of the characteristics
related to the patients in relation to the final level of
satisfaction*
Variable Coefficient 95% CI p
Age -0,72 -1,08 -0,36 <0,01
Immediate 0,99 -0,45 2,42 0,18
pain score
Impression of 0,82 0,70 0,95 <0,01
clinical 
improvement 
after 60 days 
Intercept - - - <0,01
* Dependent variable: level of satisfaction after 60 days; 
p (of the model) < 0,01
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DISCUSSION
Photodynamic therapy is a non-invasive treat-
ment, causes no bleeding, treats large areas with sin-
gle application and has good cosmetic results.
Because of these advantages it is considered an impor-
tant therapeutic option in actinic keratoses and its use
has increased considerably in the treatment of
Bowen´s disease, superficial basal cell carcinoma and
actinic cheilitis.12-22
In the present study, the collateral effects pre-
sented by the patients were comparable with the ones
already described in the literature. Berkin, Herzinger,
Flaig, Brenner, Borelli and Degitz12 performed two
applications of PDT (one week apart) in the lower lip
of 15 patients, with ages and phototypes similar to the
ones in our study, and also observed pain, crusts for-
mation, edema and herpes flare-up as the more com-
mon complaints from the patients.
Pain is one of the main adverse effects of PDT. A
retrospective study performed by Gholam et al, com-
pared the pain from PDT in various cosmetic units
(dorsum of the hands, lips, and malar, frontal and
occipital regions).23 The authors concluded that the
intensity of the pain was higher in the lips and
decreased significantly 8 hours after the application.
In the present study moderate pain was reported by
the patients, with significant decrease after treatment,
which indicates that the pain was short lived.  
The clinical improvement of actinic cheilitis was
analyzed in a study in which 19 patients were subject-
ed to 1, 2 or 3 sessions of PDT.21 In the groups of
FIGURE 1: Actinic cheilitis in the lower lip. Before (left) and after (right) 2 months of PDT application 
FIGURE 2: Actinic cheilitis in the lower lip. Before (left) and after (right) 2 months of PDT application  
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patients subjected to 1 or 2 applications a complete
clinical improvement was seen in 47% of the cases and
in the group subjected to 3 sessions, in 68%. No
histopathological evaluations were performed. The
level of improvement by the patients´ assessment in
our study was higher 2 months after the treatment
than after 1 week, which indicates that the improve-
ment was better perceived in the long run.  We also
assessed the patients´ satisfaction with the treatment,
which had a high median (85%) after 2 months and
correlated with the improvement perceived by the
patients. However, there was an inverse correlation
between satisfaction and age, which indicates that
younger individuals can better tolerate the applica-
tion. Patient satisfaction was not significantly influ-
enced by the pain attributed to the procedure.   
As for the histopathological analysis, we
observed persistence of the dysplasia after treatment
in 13 patients (84%), however, there was a significant
reduction of its intensity. One of the limitations of our
study was the application of only one session of PDT.
On the other hand, the study by Berkin, Herzinger,
Flaig, Brenner, Borelli and Degitz12 demonstrated that
after two applications of PDT, 62% of the patients still
had dysplasia. We believe that more studies are neces-
sary in order to define the ideal number of applica-
tions for the effective treatment of these lesions. 
CONCLUSION
We concluded that photodynamic therapy is an
effective tool in the treatment of actinic cheilitis, how-
ever it is frequently associated with a significant level
of pain. Despite the presence of moderate pain,
patient satisfaction was not compromised. q
FIGURE 3: Left – anatomopathological exam before the performance of PDT; actinic cheilitis, common variant, discrete level of dysplasia
and discrete inflammatory infiltrate, lymphocytic type.  Right – anatomopathological exam 2 months after application of PDT; absence of
dysplasia and  absence of inflammatory infiltrate. HE, aumento 100x 
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